Ketamine Induces Mitochondrial Fission and Dysfunction in Cervical Cancer Cells via RhoA‐Dependent DRP‐1 Activation
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Yanfang Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Qianjiang Central Hospital of Hubei Province, Qianjiang, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Mitochondrial Dynamics, rhoA GTP-Binding Protein, Dynamins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: This study was funding Hubei provincial hospital of TCM..
Abstract (Originalsprache)
Mitochondrial fragmentation, which is closely linked to mitochondrial dysfunction, has emerged as a critical treatment target for cervical cancer. Ketamine, a well‐known anesthetic, has shown potential in cancer therapy by inducing cytotoxicity, impairing mitochondrial function, and promoting apoptosis in tumor cells. Notably, the regulatory role of ketamine in mitochondrial network dynamics remains unexplored in current scientific literature. In this study, we demonstrated that ketamine exerts significant cytotoxic effects on C33A cervical cancer cells, as evidenced by dose‐dependent increases in γ‐glutamyl transpeptidase (GGT) levels and lactate dehydrogenase (LDH) release, accompanied by a corresponding reduction in cell viability. At 100 μM, ketamine induces mitochondrial dysfunction, characterized by decreased Complex IV activity, mitochondrial membrane potential (MMP), and ATP production, along with mitochondrial fragmentation. Mechanistically, ketamine upregulates mitochondrial p‐Drp1 levels without altering total DRP‐1 and enhances the expression of CaMK II and RhoA, but not Rac1/Cdc42. Inhibition of RhoA, but not CaMK II, attenuates ketamine‐induced mitochondrial DRP‐1 activation, fragmentation, and dysfunction, suggesting that RhoA is a key mediator. These findings highlight ketamine's potential as a therapeutic agent targeting mitochondrial dynamics in cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Qianjiang Central Hospital of Hubei Province, Qianjiang, China.
- Department of Anesthesiology, Ezhou Central Hospital, Ezhou, China.
- Department of Gynecology, Hubei provincial hospital of TCM, Wuhan, China.
ORCID-Profile: Ye Zhu
Förderung
- This study was funding Hubei provincial hospital of TCM.
Zitieren
APA
Zhou, Y., Chen, G., & Zhu, Y. (2025). Ketamine Induces Mitochondrial Fission and Dysfunction in Cervical Cancer Cells via RhoA‐Dependent DRP‐1 Activation. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70500
Vancouver
Zhou Y, Chen G, Zhu Y. Ketamine Induces Mitochondrial Fission and Dysfunction in Cervical Cancer Cells via RhoA‐Dependent DRP‐1 Activation. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70500
BibTeX
@article{Zhou2025,
author = {Zhou, Yanfang and Chen, Guangming and Zhu, Ye},
title = {Ketamine Induces Mitochondrial Fission and Dysfunction in Cervical Cancer Cells via RhoA‐Dependent DRP‐1 Activation},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70500}
}
EUVIMED